Artificial intelligence (AI) is already proving to be one of the most results-driving technologies used by life science companies in 2023. AI is currently being explored by 79% of biopharma companies, who are combining or exploring the combination of humans and AI in various initiatives, including responding to medical information (MI) inquiries from healthcare professionals…